These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 16750332)
1. A Phase I study of weekly intravenous oxaliplatin in combination with oral daily capecitabine and radiation therapy in the neoadjuvant treatment of rectal adenocarcinoma. Fakih MG; Rajput A; Yang GY; Pendyala L; Toth K; Smith JL; Lawrence DD; Rustum YM Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1462-70. PubMed ID: 16750332 [TBL] [Abstract][Full Text] [Related]
2. Phase II study of weekly intravenous oxaliplatin combined with oral daily capecitabine and radiotherapy with biologic correlates in neoadjuvant treatment of rectal adenocarcinoma. Fakih MG; Bullarddunn K; Yang GY; Pendyala L; Toth K; Andrews C; Rustum YM; Ross ME; Levea C; Puthillath A; Park YM; Rajput A Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):650-7. PubMed ID: 18565686 [TBL] [Abstract][Full Text] [Related]
3. Phase I-II trial of cetuximab, capecitabine, oxaliplatin, and radiotherapy as preoperative treatment in rectal cancer. Rödel C; Arnold D; Hipp M; Liersch T; Dellas K; Iesalnieks I; Hermann RM; Lordick F; Hinke A; Hohenberger W; Sauer R Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1081-6. PubMed ID: 17881150 [TBL] [Abstract][Full Text] [Related]
4. Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901. ; Ryan DP; Niedzwiecki D; Hollis D; Mediema BE; Wadler S; Tepper JE; Goldberg RM; Mayer RJ J Clin Oncol; 2006 Jun; 24(16):2557-62. PubMed ID: 16636336 [TBL] [Abstract][Full Text] [Related]
5. A phase I dose escalation study of continuous oral capecitabine in combination with oxaliplatin and pelvic radiation (XELOX-RT) in patients with locally advanced rectal cancer. Glynne-Jones R; Sebag-Montefiore D; Maughan TS; Falk SJ; McDonald AC Ann Oncol; 2006 Jan; 17(1):50-6. PubMed ID: 16284060 [TBL] [Abstract][Full Text] [Related]
6. A phase II study of neoadjuvant chemoradiotherapy with oxaliplatin and capecitabine for rectal cancer. Zhao L; Bai C; Shao Y; Guan M; Jia N; Xiao Y; Qiu H; Zhang F; Yang T; Zhong G; Chen S Cancer Lett; 2011 Nov; 310(2):134-9. PubMed ID: 21782322 [TBL] [Abstract][Full Text] [Related]
7. Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer. Rödel C; Grabenbauer GG; Papadopoulos T; Hohenberger W; Schmoll HJ; Sauer R J Clin Oncol; 2003 Aug; 21(16):3098-104. PubMed ID: 12915600 [TBL] [Abstract][Full Text] [Related]
8. Phase I study of oxaliplatin in combination with capecitabine and radiotherapy as postoperative treatment for stage II and III rectal cancer. Jin J; Li YX; Wang JW; Wang WH; Liu YP; Wang K; Fang H; Zhou ZX; Zhou AP; Yu ZH Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):671-7. PubMed ID: 18455328 [TBL] [Abstract][Full Text] [Related]
9. Preoperative chemoradiotherapy with capecitabine and oxaliplatin in locally advanced rectal cancer. A phase I-II multicenter study of the Dutch Colorectal Cancer Group. Hospers GA; Punt CJ; Tesselaar ME; Cats A; Havenga K; Leer JW; Marijnen CA; Jansen EP; Van Krieken HH; Wiggers T; Van de Velde CJ; Mulder NH Ann Surg Oncol; 2007 Oct; 14(10):2773-9. PubMed ID: 17653805 [TBL] [Abstract][Full Text] [Related]
10. A phase I study of concurrent radiotherapy and capecitabine as adjuvant treatment for operable rectal cancer. Jin J; Li YX; Liu YP; Wang WH; Song YW; Li T; Li N; Yu ZH; Liu XF Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):725-9. PubMed ID: 16242260 [TBL] [Abstract][Full Text] [Related]
11. Capecitabine plus weekly oxaliplatin in gastrointestinal tumors: a phase I study. Carlomagno C; Orditura M; Pepe S; De Vita F; Romano C; Ciardiello F; Ferrara C; Martinelli E; Bianco R; Aurilio G; D'Agostino D; Tortora G; Catalano G; De Placido S Am J Clin Oncol; 2006 Feb; 29(1):85-9. PubMed ID: 16462509 [TBL] [Abstract][Full Text] [Related]
12. [Phase I study of postoperative concurrent chemoradiation with capecitabine as adjuvant treatment for stage II/III operable rectal cancer]. Jin J; Li YX; Liu YP; Wang WH; Li T; Li N; Song YW Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):393-6. PubMed ID: 17045010 [TBL] [Abstract][Full Text] [Related]
13. Thymidine phosphorylase to dihydropyrimidine dehydrogenase ratio as a predictive factor of response to preoperative chemoradiation with capecitabine in patients with advanced rectal cancer. Boskos CS; Liacos C; Korkolis D; Aygerinos K; Lamproglou I; Terpos E; Stoupa E; Baltatzis G; Beroukas K; Papasavvas P; Dimopoulos MA; Bamias A J Surg Oncol; 2010 Oct; 102(5):408-12. PubMed ID: 19877119 [TBL] [Abstract][Full Text] [Related]
14. Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer. Rödel C; Liersch T; Hermann RM; Arnold D; Reese T; Hipp M; Fürst A; Schwella N; Bieker M; Hellmich G; Ewald H; Haier J; Lordick F; Flentje M; Sülberg H; Hohenberger W; Sauer R J Clin Oncol; 2007 Jan; 25(1):110-7. PubMed ID: 17194912 [TBL] [Abstract][Full Text] [Related]
15. Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction. Spigel DR; Greco FA; Meluch AA; Lane CM; Farley C; Gray JR; Clark BL; Burris HA; Hainsworth JD J Clin Oncol; 2010 May; 28(13):2213-9. PubMed ID: 20351330 [TBL] [Abstract][Full Text] [Related]
16. Oxaliplatin and capecitabine-based chemoradiotherapy for gastric cancer--an extended phase I MARGIT and AIO trial. Hofheinz RD; Wenz F; Lukan N; Mai S; Kripp M; Staiger W; Schwarzbach M; Willeke F; Möhler M; Post S; Hochhaus A Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):142-7. PubMed ID: 18539404 [TBL] [Abstract][Full Text] [Related]
17. Simultaneous integrated boost-intensity modulated radiation therapy with concomitant capecitabine and mitomycin C for locally advanced anal carcinoma: a phase 1 study. Deenen MJ; Dewit L; Boot H; Beijnen JH; Schellens JH; Cats A Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):e201-7. PubMed ID: 23517808 [TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer. Chau I; Brown G; Cunningham D; Tait D; Wotherspoon A; Norman AR; Tebbutt N; Hill M; Ross PJ; Massey A; Oates J J Clin Oncol; 2006 Feb; 24(4):668-74. PubMed ID: 16446339 [TBL] [Abstract][Full Text] [Related]
19. Combined radiotherapy, 5-fluorouracil continuous infusion and weekly oxaliplatin in advanced rectal cancer: a phase I study. François E; Ychou M; Ducreux M; Bertheault-Cvitkovic F; Giovannini M; Conroy T; Lemanski C; Thomas O; Magnin V; Eur J Cancer; 2005 Dec; 41(18):2861-7. PubMed ID: 16297614 [TBL] [Abstract][Full Text] [Related]
20. Capecitabine, irinotecan, oxaliplatin (CAPIRINOX) and concomitant irradiation in advanced rectal cancer: the Lyon R-02-01 phase I trial. Heudel P; Romestaing P; Barbet N; Falandry C; You B; Glehen O; Freyer G Clin Oncol (R Coll Radiol); 2008 Jun; 20(5):369-74. PubMed ID: 18406583 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]